EC

Eli Casdin

Chief Investment Officer at Casdin Capital

New York, New York

Overview 

Eli Casdin is the Chief Investment Officer at Casdin Capital, investing in various sectors including Consumer Health, BioTech, and Digital Health. With a background in finance and extensive experience, he has served on the boards of multiple organizations such as The Rockefeller University and New York Genome Center, and has made successful investments in companies like Century Therapeutics and C2i Genomics.

Work Experience 

  • Chief Investment Officer

    2011 - Current

Casdin Capital is a fundamental research investment firm focused on the life sciences and healthcare industry.

  • Board Member

    2020

The mission of New York Genome Center is to save lives by creating an unprecedented collaboration of technology, science, and medicine.

Raised $131,000,000.00 from Simons Foundation, The Carson Family Charitable Trust, Alfred P. Sloan Foundation and Alfred P. Sloan Foundation.

  • Board Member

    2022

  • Board Member

    2020

GeneDx uses artificial intelligence and machine learning to analyze patient data to provide insights to transform the practice of medicine.

Raised $941,000,000.00 from Pfizer, SoftBank Capital, Deerfield, Perceptive Advisors, Counterpoint Global, Viking Global Investors, T. Rowe Price, Casdin Capital, BlackRock and Fidelity.

  • Board Member

    2018

JJDC finds transformative ideas and helps them mature into real solutions for today’s patients.

  • Board Member

    2018

Genomatica manufactures sustainable chemicals from renewable feedstocks.

Raised $340,252,740.00 from Lululemon.

  • Board Member

    2020 - 2024

SomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.

Raised $956,517,993.00 from Casdin Capital, T. Rowe Price, Illumina, Farallon Capital Management, SoftBank Capital, Perceptive Advisors, Counterpoint Global, ARK Investment Management, Corvex and Janus Henderson Investors.

  • Board Member

    2019 - 2022

Articles About Eli

Relevant Websites